Lina Gunnarsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lina Gunnarsson has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Dan Göran Joakim Larsson
Centre for Antibiotic Resistance Research in Gothenburg (CARe), University of Gothenburg, Gothenburg, Sweden
14 shared publications Erik Kristiansson
Department of Mathematical Sciences, Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden
4 shared publicationsCarolin Rutgersson
Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
3 shared publications- Erik Kristiansson
Department of Mathematical Sciences, Chalmers University of Technology/University of Gothenburg, Gothenburg, Sweden
3 shared publications Jerker Fick
∥Department of Chemistry, Umeå University, Umeå SE-901 87, Sweden
3 shared publicationsBerndt Björlenius
§Division of Industrial Biotechnology, Royal Institute of Technology, Stockholm SE-106 91, Sweden
2 shared publications
Latest Publications
- 1 January 2018
- Published by Elsevier in Journal of Cleaner Production
- Vol. 171, 137-146
Can branding and price of pharmaceuticals guide informed choices towards improved pollution control during manufacturing?
- 1 January 2018
- Published by Elsevier in Journal of Cleaner Production
- Vol. 171, 137-146
Can branding and price of pharmaceuticals guide informed choices towards improved pollution control during manufacturing?
- Open Access
- 1 December 2017
- Published by Elsevier in Environment International
- Vol. 109, 155-169
Integrating human and environmental health in antibiotic risk assessment: A critical analysis of protection goals, species sensitivity and antimicrobial resistance
- 1 December 2017
- Published by Elsevier in Environment International
- Vol. 109, 155-169
Open AccessIntegrating human and environmental health in antibiotic risk assessment: A critical analysis of protection goals, species sensitivity and antimicrobial resistance
- Open Access
- 13 May 2015
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 13 (1) , 1-10
Progesterone-mediated effects on gene expression and oocyte-cumulus complex transport in the mouse fallopian tube
The fallopian tube transports the gametes to the fertilization site and delivers the embryo to the uterus at the optimal time for implantation. Progesterone and the classical progesterone receptor are involved in regulating both tubal ciliary beating and muscular contractions, likely via both genomic and non-genomic actions. To provide more details of the underlying mechanisms, we investigated the effect of progesterone on gene expression in mice fallopian tubes in vitro at 20 min, 2 h and 8 h post progesterone treatment using microarray and/or quantitative PCR. In parallel, oocyte cumulus complex transport was investigated in ovulating mice that were injected with one of the progesterone receptor antagonists, Org 31710 or CDB2194. Microarray analyses did not reveal any apparently regulated genes 20 min after progesterone treatment, consistent with the proposed non-genomic action of progesterone controlling ciliary beating. After 2 h, 11 genes were identified as up-regulated. Analyses using quantitative PCR at 2 h and 8 h showed a consistent up-regulation of endothelin1 and a down-regulation of its receptor Endothelin receptor A by progesterone. We also confirmed that treatment with progesterone receptor antagonists before ovulation accelerates the transport of the oocyte cumulus complex. This is the first study showing that progesterone regulates the expression of endothelin1 and endothelin receptor A in the fallopian tube. Together with previous studies of the effects of endothelin on muscular contractions in the fallopian tube, the results from this study suggest that endothelin is a mediator of the progesterone-controlled effects on muscular contraction and eventually gamete transport in the fallopian tube.
- 13 May 2015
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 13 (1) , 1-10
Open AccessProgesterone-mediated effects on gene expression and oocyte-cumulus complex transport in the mouse fallopian tube
The fallopian tube transports the gametes to the fertilization site and delivers the embryo to the uterus at the optimal time for implantation. Progesterone and the classical progesterone receptor are involved in regulating both tubal ciliary beating and muscular contractions, likely via both genomic and non-genomic actions. To provide more details of the underlying mechanisms, we investigated the effect of progesterone on gene expression in mice fallopian tubes in vitro at 20 min, 2 h and 8 h post progesterone treatment using microarray and/or quantitative PCR. In parallel, oocyte cumulus complex transport was investigated in ovulating mice that were injected with one of the progesterone receptor antagonists, Org 31710 or CDB2194. Microarray analyses did not reveal any apparently regulated genes 20 min after progesterone treatment, consistent with the proposed non-genomic action of progesterone controlling ciliary beating. After 2 h, 11 genes were identified as up-regulated. Analyses using quantitative PCR at 2 h and 8 h showed a consistent up-regulation of endothelin1 and a down-regulation of its receptor Endothelin receptor A by progesterone. We also confirmed that treatment with progesterone receptor antagonists before ovulation accelerates the transport of the oocyte cumulus complex. This is the first study showing that progesterone regulates the expression of endothelin1 and endothelin receptor A in the fallopian tube. Together with previous studies of the effects of endothelin on muscular contractions in the fallopian tube, the results from this study suggest that endothelin is a mediator of the progesterone-controlled effects on muscular contraction and eventually gamete transport in the fallopian tube.
- Open Access
- 6 April 2015
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 49 (9) , 5336-5345
Improving Environmental Risk Assessment of Human Pharmaceuticals
This paper presents 10 recommendations for improving the European Medicines Agency’s guidance for environmental risk assessment of human pharmaceutical products. The recommendations are based on up-to-date, available science in combination with experiences from other chemical frameworks such as the REACH-legislation for industrial chemicals. The recommendations concern: expanding the scope of the current guideline; requirements to assess the risk for development of antibiotic resistance; jointly performed assessments; refinement of the test proposal; mixture toxicity assessments on active pharmaceutical ingredients with similar modes of action; use of all available ecotoxicity studies; mandatory reviews; increased transparency; inclusion of emission data from production; and a risk management option. We believe that implementation of our recommendations would strengthen the protection of the environment and be beneficial to society. Legislation and guidance documents need to be updated at regular intervals in order to incorporate new knowledge from the scientific community. This is particularly important for regulatory documents concerning pharmaceuticals in the environment since this is a research field that has been growing substantially in the last decades.
- 6 April 2015
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 49 (9) , 5336-5345
Open AccessImproving Environmental Risk Assessment of Human Pharmaceuticals
This paper presents 10 recommendations for improving the European Medicines Agency’s guidance for environmental risk assessment of human pharmaceutical products. The recommendations are based on up-to-date, available science in combination with experiences from other chemical frameworks such as the REACH-legislation for industrial chemicals. The recommendations concern: expanding the scope of the current guideline; requirements to assess the risk for development of antibiotic resistance; jointly performed assessments; refinement of the test proposal; mixture toxicity assessments on active pharmaceutical ingredients with similar modes of action; use of all available ecotoxicity studies; mandatory reviews; increased transparency; inclusion of emission data from production; and a risk management option. We believe that implementation of our recommendations would strengthen the protection of the environment and be beneficial to society. Legislation and guidance documents need to be updated at regular intervals in order to incorporate new knowledge from the scientific community. This is particularly important for regulatory documents concerning pharmaceuticals in the environment since this is a research field that has been growing substantially in the last decades.
- 1 April 2015
- Published by Elsevier in Science of The Total Environment
- Vol. 511, 37-46
Waterborne beclomethasone dipropionate affects the physiology of fish while its metabolite beclomethasone is not taken up
- 1 April 2015
- Published by Elsevier in Science of The Total Environment
- Vol. 511, 37-46
Waterborne beclomethasone dipropionate affects the physiology of fish while its metabolite beclomethasone is not taken up
- 19 November 2014
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 369 (1656) , 20130576
Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecology
Fish represent the planet's most diverse group of vertebrates and they can be exposed to a wide range of pharmaceuticals. For practical reasons, extrapolation of pharmaceutical effects from ‘model’ species to other fish species is adopted in risk assessment. Here, we critically assess this approach. First, we show that between 65% and 86% of human drug targets are evolutionarily conserved in 12 diverse fish species. Focusing on nuclear steroid hormone receptors, we further show that the sequence of the ligand binding domain that plays a key role in drug potency is highly conserved, but there is variation between species. This variation for the oestrogen receptor, however, does not obviously account for observed differences in receptor activation. Taking the synthetic oestrogen ethinyloestradiol as a test case, and using life-table-response experiments, we demonstrate significant reductions in population growth in fathead minnow and medaka, but not zebrafish, for environmentally relevant exposures. This finding contrasts with zebrafish being ranked as more ecologically susceptible, according to two independent life-history analyses. We conclude that while most drug targets are conserved in fish, evolutionary divergence in drug-target activation, physiology, behaviour and ecological life history make it difficult to predict population-level effects. This justifies the conventional use of at least a 10× assessment factor in pharmaceutical risk assessment, to account for differences in species susceptibility.
- 19 November 2014
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 369 (1656) , 20130576
Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecology
Fish represent the planet's most diverse group of vertebrates and they can be exposed to a wide range of pharmaceuticals. For practical reasons, extrapolation of pharmaceutical effects from ‘model’ species to other fish species is adopted in risk assessment. Here, we critically assess this approach. First, we show that between 65% and 86% of human drug targets are evolutionarily conserved in 12 diverse fish species. Focusing on nuclear steroid hormone receptors, we further show that the sequence of the ligand binding domain that plays a key role in drug potency is highly conserved, but there is variation between species. This variation for the oestrogen receptor, however, does not obviously account for observed differences in receptor activation. Taking the synthetic oestrogen ethinyloestradiol as a test case, and using life-table-response experiments, we demonstrate significant reductions in population growth in fathead minnow and medaka, but not zebrafish, for environmentally relevant exposures. This finding contrasts with zebrafish being ranked as more ecologically susceptible, according to two independent life-history analyses. We conclude that while most drug targets are conserved in fish, evolutionary divergence in drug-target activation, physiology, behaviour and ecological life history make it difficult to predict population-level effects. This justifies the conventional use of at least a 10× assessment factor in pharmaceutical risk assessment, to account for differences in species susceptibility.
- Open Access
- 27 February 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 70
A novel method for cross-species gene expression analysis
Analysis of gene expression from different species is a powerful way to identify evolutionarily conserved transcriptional responses. However, due to evolutionary events such as gene duplication, there is no one-to-one correspondence between genes from different species which makes comparison of their expression profiles complex.
- 27 February 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 70
Open AccessA novel method for cross-species gene expression analysis
Analysis of gene expression from different species is a powerful way to identify evolutionarily conserved transcriptional responses. However, due to evolutionary events such as gene duplication, there is no one-to-one correspondence between genes from different species which makes comparison of their expression profiles complex.
- Open Access
- 19 December 2012
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 32 (3) , 577-584
Oral exposure to industrial effluent with exceptionally high levels of drugs does not indicate acute toxic effects in rats
The Patancheru area near Hyderabad in India is recognized as a key link in the global supply chain for many bulk drugs. A central treatment plant receives wastewater from approximately 90 different manufacturers, and the resulting complex effluent has contaminated surface, ground, and drinking water in the region. Ecotoxicological testing of the effluent has shown adverse effects for several organisms, including aquatic vertebrates, at high dilutions. In addition, a recent study of microbial communities in river sediment indicated that the contamination of antibiotic substances might contribute to the emergence and spread of antibiotic resistance genes. In an attempt to start investigating how exposure to effluent-contaminated water may directly affect humans and other terrestrial vertebrates, rats were tube-fed effluent. Several pharmaceuticals present in the effluent could be detected in rat blood serum at low concentrations. However, results from exploratory microarray and quantitative polymerase chain reaction assays indicated no marked effects on hepatic gene transcription after 5 d of exposure. Clinical analysis of blood serum constituents, used as biomarkers for human disease did not reveal any significant changes, nor was there an effect on weight gain. The authors could not find evidence for any acute toxicity in the rat; however, the authors cannot rule out that higher doses of effluent or a longer exposure time may still be associated with risks for terrestrial vertebrates. Environ. Toxicol. Chem. 2013;32:577–584. © 2012 SETAC
- 19 December 2012
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 32 (3) , 577-584
Open AccessOral exposure to industrial effluent with exceptionally high levels of drugs does not indicate acute toxic effects in rats
The Patancheru area near Hyderabad in India is recognized as a key link in the global supply chain for many bulk drugs. A central treatment plant receives wastewater from approximately 90 different manufacturers, and the resulting complex effluent has contaminated surface, ground, and drinking water in the region. Ecotoxicological testing of the effluent has shown adverse effects for several organisms, including aquatic vertebrates, at high dilutions. In addition, a recent study of microbial communities in river sediment indicated that the contamination of antibiotic substances might contribute to the emergence and spread of antibiotic resistance genes. In an attempt to start investigating how exposure to effluent-contaminated water may directly affect humans and other terrestrial vertebrates, rats were tube-fed effluent. Several pharmaceuticals present in the effluent could be detected in rat blood serum at low concentrations. However, results from exploratory microarray and quantitative polymerase chain reaction assays indicated no marked effects on hepatic gene transcription after 5 d of exposure. Clinical analysis of blood serum constituents, used as biomarkers for human disease did not reveal any significant changes, nor was there an effect on weight gain. The authors could not find evidence for any acute toxicity in the rat; however, the authors cannot rule out that higher doses of effluent or a longer exposure time may still be associated with risks for terrestrial vertebrates. Environ. Toxicol. Chem. 2013;32:577–584. © 2012 SETAC
- 1 June 2012
- Published by Elsevier in Science of The Total Environment
- Vol. 427-428, 106-114
Global hepatic gene expression in rainbow trout exposed to sewage effluents: A comparison of different sewage treatment technologies
- 1 June 2012
- Published by Elsevier in Science of The Total Environment
- Vol. 427-428, 106-114
Global hepatic gene expression in rainbow trout exposed to sewage effluents: A comparison of different sewage treatment technologies
- 5 May 2012
- Published by Springer Nature
- p. 85-108
Environmental Comparative Pharmacology: Theory and Application
- 5 May 2012
- Published by Springer Nature
- p. 85-108
Environmental Comparative Pharmacology: Theory and Application